Latest News

  • Kalbe and Ministry of Research & Technology Holds a National Seminar Ristek-Kalbe Science Awards 2014

    Themed Synergy on Implementable Research and Development of Science and Technology

    Thursday, March 20, 2014

    Surabaya, 20 March 2014 – PT Kalbe Farma Tbk (Kalbe) In collaboration with the Ministry of Research and Technology of the Republic of Indonesia (MRT RI) today holds a National seminar with the theme of "Optimization of Academics, Industry, and Government to Devise Superior and Implementable National Research" as part of the Ristek-Kalbe Science Awards (RKSA) 2014 activities, at Graha BIK IPTEK-DOK, Faculty of Medicine, Airlangga University. The Ristek-Kalbe Science Awards itself is an event to appreciate the best researchers in Indonesia. The seminar that was attended by 150 researchers and academics presented speakers from the academics, business, and government parties.

  • Kalbe Launches ReGeniC

    Hollistic Stem Cell Education Service

    Saturday, March 8, 2014

    Bogor, 8 March 2014 – PT Kalbe Farma Tbk (Kalbe) through its subsidiary PT Bifarma Adiluhung today launches its ReGeniC (Regenerative and Cellular Therapy) brand. ReGeniC is the service unit on Stem Cell and education center on stem cell services for the public.  In the event that is attended by 11 chairpersons of Indonesian hospitals that has the license to do stem cell services, a number of development on the science and regulations on stem cells. 

  • Kalbe Shares Movement for Healthy Kelud

    Tuesday, February 25, 2014

    Kediri, 25 February 2014 – PT Kalbe Farma Tbk (Kalbe) today holds social services in the form of health services, clean water provision, and donations of tarp for the families who are victims of the eruption of Mount Kelud, Kediri, East Java. The activities are centered at Kebon Rejo Village post, Kepung District, Kediri Regency; which is about 5 KM away from the foot of Mt. Kelud.
  • Indicative Net Sales for 2013 Increased by 17.4%

    Wednesday, February 12, 2014

    Jakarta, February 12, 2014 – PT Kalbe Farma Tbk and its subsidiaries (“Kalbe” or “the Company”) today announced the Company’s indicative performance (unaudited) for the year 2013. Indicative consolidated sales reached Rp 16.01 Trillion for year 2013, an increase of approximately 17.4% compared to Rp 13.64 Trillion last year.
  • Kalbe Signs Agreements with Ministry of Research and Technology

    Synergy of Science and Technological Research and Development on Healthcare

    Tuesday, February 11, 2014

    Jakarta, 11 February 2014 – PT Kalbe Farma Tbk (Kalbe) and the Ministry of Research and Technoloy of Republic of Indonesia today sign a mutual agreement to synergize the research and development of science in the healthcare field. The signing of the agreement takes place at the Kemenristek building, Jakarta, and attended byt he Minister of Research and Technology, Prof. Dr. Ir. H. Gusti Muhammad Hatta MS and President Director of PT Kalbe Farma Tbk Irawati Setiady.